Avon’s Options Are Limited
Avon Products and its shareholders are in big trouble. The company's revenue has been declining steadily since 2011.
Archive
Year: 2015
All Year: 2015 Articles
Newest first · Page 222Meet the New Dallas Fed President
The Federal Reserve Bank of Dallas has announced who will formally replace Richard Fisher as the new president and chief executive officer of the district bank.
Is Bullish Analyst View of JC Penney Reasonable?
While it often does not make a lot of sense to argue with experts about something in their field of expertise, every so often it clears the head.
Are Zulily Shareholders Getting Enough in the QVC Buyout?
Liberty Interactive and Zulily announced that they have entered into a definitive agreement under which the former will acquire all outstanding shares of the latter.
The Driving Force Behind a 50% Rally in Sprint Shares
Sprint has become a massive stock performer. How many other mobile carriers can say that their stock has risen about 50% in just two weeks?
Airlines Passengers Have More Complaints Than Ever
U.S. Transportation Department's statistical bureau showed that complaints from U.S. travelers rose more than 20% in the first six months of 2015.
Homebuilder Confidence at 9-Year High in August
The National Association of Home Builders (NAHB)/Wells Fargo housing market index for August increased by one point to the highest reading since November 2005.
Philip Morris Scores Key Upgrade With Dividend Hike Expectations
Philip Morris International might be looking to entice more investors with an even stronger dividend, or at least one key analyst thinks so.
A Micron Analyst Upgrade That Feels Like a Downgrade
Micron Technology recently held its analyst day, and there has been a mixed view on the largest dynamic random-access memory (DRAM) maker.
New York Fed Empire Manufacturing Falls Off a Cliff
Business activity declined for New York manufacturers in August to its the lowest level since 2009.
90 Years of Automobile Fuel Economy Advances
Researchers at the University of Michigan Transportation Institute have calculated the on-road fuel economy of all vehicles in the U.S. fleet between the years of 1923 and 2013.
Kite Pharma Updates Study, Dispells Rumors
Kite Pharma gave an update from its ongoing Phase 1/2 clinical trial of KTE-C19 in patients with refractory aggressive non-Hodgkin's lymphoma.
Jefferies Raises Price Targets on 3 Top Growth Stocks to Buy Now
A new research report from Jefferies zeroes in on top new growth stocks to buy that are not part of overcrowded trades or momentum hype.
Is AVEO the Next Aquinox for Traders?
Aveo Pharmaceuticals made waves in early trading indications Monday on news of a licensing agreement with Novartis.
3 Merrill Lynch Alternative Energy Stock Picks With Big Dividends
All these companies are executing well, and patient investors that have the ability to handle the volatility may be rewarded handsomely.